|
1P-08-Delta 8-THC Facts-Dec 2021 |
|
|
FY 2021 Agency Financial Report |
|
|
FY 2019 PSA CBJ |
|
|
FY 2020 PSA CBJ |
|
|
FY 2021 PSA CBJ |
|
|
FY 2022 PSA CBJ |
|
|
Pretrial Risk Assessment in DC Status Statement February 2022 |
|
|
Fact Sheet: Arrest Free Rates for DC Defendants Under Pretrial Supervision-FY2016-20 |
|
|
Fact Sheet: PSA Performance Outcomes-FY2016-20 |
|
|
Fact Sheet: PSA Performance Outcomes-FY2017-21 |
|
|
Fact Sheet: Release Rates for DC Defendants-FY2021 |
|
|
Fact Sheet: Release Rates for DC Pretrial Defendants-FY2020 |
|
|
Fact Sheet: Arrest-Free Rates for DC Defendants Released to the Community-FY2017-2021 |
|
|
1P-01-Leading in the Field-June 2018 |
|
|
1P-04-SSAC-June 2018 |
|
|
1P-05-Drug Court-June 2018 |
|
|
1P-06-HISP-June 2018 |
|
|
1P-07-Alcohol and EtG Drug Testing Facts-Oct 2019 |
|
|
FY 2023 PSA CBJ |
|
|
PSA's Programs and Services (one-pager) June 2022 |
|
